In a challenging market environment, Tilray Inc (NASDAQ:TLRY) stock has reached a 52-week low, dipping to $1.06. The cannabis company, which has been navigating through regulatory hurdles and intense ...

During the past five years, the reality of the cannabis industry has not lived up to the hype that accompanied Canada's ...

Trudeau's legalization legacy shaped Canada's global cannabis leadership. Conservative leadership risks policy stagnation & economic setbacks; publicly traded weed companies face uncertainty amid ...

In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against other pot stocks to buy according to analysts. The global marijuana market is growing and the ...

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...

For those cheering from home, indulge in the ultimate to-go pack, perfect for a home feast, or savor the Game Day feast to-go ...

Tilray Brands Inc. closed 62.96% below its 52-week high of $2.97, which the company reached on April 4th.

Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its ...

Cannabis stocks have largely generated abysmal returns during much of that time. Tilray Brands (NASDAQ: TLRY), a leader in the sector, is no exception. However, the company has made significant ...

There could be progress on the cannabis legalization front in the next five years. Whether Tilray benefits from this will depend on a lot of factors. The company's outlook remains risky and uncertain.